ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.
ClinGen Variant Curation Expert Panel experiences and standardized processes for disease and gene-level specification of the ACMG/AMP guidelines for sequence variant interpretation.
复制标题
DOI:
10.1002/humu.23645
复制
发表时间:
2018-11
期刊:
影响因子:
3.9
通讯作者:
Berg JS
中科院分区:
文献类型:
--
作者:
Rivera-Muñoz EA;Milko LV;Harrison SM;Azzariti DR;Kurtz CL;Lee K;Mester JL;Weaver MA;Currey E;Craigen W;Eng C;Funke B;Hegde M;Hershberger RE;Mao R;Steiner RD;Vincent LM;Martin CL;Plon SE;Ramos E;Rehm HL;Watson M;Berg JS
Genome-scale sequencing creates vast amounts of genomic data, increasing the challenge of clinical sequence variant interpretation. The demand for high-quality interpretation requires multiple specialties to join forces to accelerate the interpretation of sequence variant pathogenicity. With over 600 international members including clinicians, researchers, and laboratory diagnosticians, the Clinical Genome Resource (ClinGen), funded by the National Institutes of Health (NIH), is forming expert groups to systematically evaluate variants in clinically relevant genes. Here, we describe the first ClinGen Variant Curation Expert Panels (VCEPs), development of consistent and streamlined processes for establishing new VCEPs, and creation of standard operating procedures (SOPs) for VCEPs to define application of the ACMG/AMP guidelines for sequence variant interpretation in specific genes or diseases. Additionally, ClinGen has created user interfaces to enhance reliability of curation and a Sequence Variant Interpretation Working Group (SVI WG) to harmonize guideline specifications and ensure consistency between groups. The expansion of VCEPs represents the primary mechanism by which curation of a substantial fraction of genomic variants can be accelerated and ultimately undertaken systematically and comprehensively. We welcome groups to utilize our resources and become involved in our effort to create a publicly accessible, centralized resource for clinically relevant genes and variants.
登录
查看更多内容
DOI:
10.1038/gim.2017.218
发表时间:
2018-03
期刊:
Genetics in medicine : official journal of the American College of Medical Genetics
影响因子:
--
作者:
Kelly MA;Caleshu C;Morales A;Buchan J;Wolf Z;Harrison SM;Cook S;Dillon MW;Garcia J;Haverfield E;Jongbloed JDH;Macaya D;Manrai A;Orland K;Richard G;Spoonamore K;Thomas M;Thomson K;Vincent LM;Walsh R;Watkins H;Whiffin N;Ingles J;van Tintelen JP;Semsarian C;Ware JS;Hershberger R;Funke B
通讯作者:
Funke B
影响因子:
3.9
作者:
Mester JL;Ghosh R;Pesaran T;Huether R;Karam R;Hruska KS;Costa HA;Lachlan K;Ngeow J;Barnholtz-Sloan J;Sesock K;Hernandez F;Zhang L;Milko L;Plon SE;Hegde M;Eng C
通讯作者:
Eng C
影响因子:
--
作者:
Furqan, Aisha;Arscott, Patricia;Caleshu, Colleen
通讯作者:
Caleshu, Colleen
影响因子:
9.8
作者:
Garber, Kathryn B.;Vincent, Lisa M.;Hegde, Madhuri
通讯作者:
Hegde, Madhuri
影响因子:
1.8
作者:
Azzariti DR;Riggs ER;Niehaus A;Rodriguez LL;Ramos EM;Kattman B;Landrum MJ;Martin CL;Rehm HL
通讯作者:
Rehm HL